AIM

ECO Animal Health Appoints Dr. Joachim Hasenmaier as Non-Executive Director

Retrieved on: 
Monday, February 12, 2024
Acquisition, The Elements of Style, Doctor of Philosophy, Boehringer Ingelheim Animal Health, Health, Growth, ECO, Veterinary medicine, MBA, AIM, Vaccine, Boehringer Ingelheim, McKinsey & Company, Animal Health, Mars, Incorporated, Ageing, Management

ECO Animal Health Group plc (AIM: EAH), a rapidly growing global animal health company with a portfolio of marketed veterinary products and a maturing proprietary R&D pipeline, announces the appointment of Dr. Joachim Hasenmaier as a Non-Executive Director, with immediate effect.

Key Points: 
  • ECO Animal Health Group plc (AIM: EAH), a rapidly growing global animal health company with a portfolio of marketed veterinary products and a maturing proprietary R&D pipeline, announces the appointment of Dr. Joachim Hasenmaier as a Non-Executive Director, with immediate effect.
  • Dr. Hasenmaier is a highly experienced commercial leader with more than two decades in the international animal health industry.
  • From 2001 to 2019 he held a variety of senior roles within the animal health division at Boehringer Ingelheim, concluding as member of the Board of Managing Directors responsible for the entire animal health division.
  • Dr. Andrew Jones, Chairman of ECO, commented: “On behalf of the Board, I am delighted to welcome Joachim as a Non-Executive Director to ECO.

Proposed Fundraising

Retrieved on: 
Monday, February 12, 2024
SRK, Engineering, EIA, Copper, Nickel, Nanoq, Weather, Mining, Mineral, Social impact assessment, Resource, ESG, Titanium, AIM, GCAM, Nasdaq First North, Halyard, Growth, Metal, Gold, National instrument, Acceleration, Graphite, Environmental impact assessment, Feasibility study, KT, Cryptocurrency

The Dolerite Dyke Model: Amaroq has worked with SRK Consulting to develop a robust Mineral Resource estimation technique for Nalunaq.

Key Points: 
  • The Dolerite Dyke Model: Amaroq has worked with SRK Consulting to develop a robust Mineral Resource estimation technique for Nalunaq.
  • Preparation for a phased ramp-up to 300 tonnes per day process plant design capacity will continue throughout the year.
  • The main initiative is accelerating development of the Target Block which will undergo trial mining in conjunction with the Mountain Block.
  • The net use of proceeds from the Fundraising will be used to fund the accelerated development of the Target Block, infrastructure investment to allow for the mining of two blocks simultaneously, preparatory works at the South & Valley Blocks, installation of the flotation circuit and DSTF, and accelerated exploration at Vagar/Nanoq and the Gardaq joint venture.

Statement Regarding Press Speculation

Retrieved on: 
Sunday, February 11, 2024
Person, Sale, Consultant, Indian stock exchange, Reproduction, Disclosure, AIM, The Act, Order, EEA, Fundraising, FSMA, London Stock Exchange, Prospectus, Financial services, Trustee, Central bank, TSX, Nature, Republic, Finance, Financial adviser

No public offering of securities is being made in the United States, Iceland, Australia, Canada, South Africa, Japan or elsewhere.

Key Points: 
  • No public offering of securities is being made in the United States, Iceland, Australia, Canada, South Africa, Japan or elsewhere.
  • Persons receiving this Announcement are required to inform themselves about and to observe any restrictions contained in this Announcement.
  • Persons distributing any part of this Announcement must satisfy themselves that it is lawful to do so.
  • The forward-looking statements contained in this Announcement speak only as at the date of this Announcement.

AIM ImmunoTech Reports Positive Topline Results from Phase 2 Study Evaluating Ampligen® for the Treatment of Post-COVID Conditions

Retrieved on: 
Thursday, February 8, 2024
Week, Trial of the century, Clutch (eggs), Safety, Science, Fatigue, AIM, Death

OCALA, Fla., Feb. 08, 2024 (GLOBE NEWSWIRE) --  AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced positive topline results from the Company’s Phase 2 study evaluating the efficacy and safety of Ampligen® as a potential therapeutic for people with the Post-COVID condition of fatigue (“AMP-518”).

Key Points: 
  • OCALA, Fla., Feb. 08, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced positive topline results from the Company’s Phase 2 study evaluating the efficacy and safety of Ampligen® as a potential therapeutic for people with the Post-COVID condition of fatigue (“AMP-518”).
  • Ampligen’s positive impact on the objective six-minute walk test is also very encouraging and useful for future trial design.
  • I’m eager to receive the complete study report, which will have outcomes for all secondary readouts, as well as individual subject data.
  • There were six subjects (15.0%) in the Ampligen group with TEAEs considered related to the study treatment, the majority of which were mild in severity.

Gateless Integrates with Freddie Mac to Offer First of its Kind Income Verification Solution

Retrieved on: 
Wednesday, February 7, 2024
Freddie Mac, AIM, LPA, W-2, Automation, Employment, Documentation, API, Sale

CHICAGO, Feb. 7, 2024 /PRNewswire/ -- Gateless, a visionary mortgage technology company, proudly announces its integration with Freddie Mac's AIM Check application programing interface (API). This integration links Gateless' intelligent automation products with Freddie Mac's AIM Check API allowing lenders to benefit from an early income assessment from Loan Product Advisor® (LPASM). Lenders will benefit from increased opportunities tied to the real-time calculation of qualified income, and the inherent operational efficiency, accelerated borrower experience, and lender certainty, which comes with that calculation.

Key Points: 
  • CHICAGO, Feb. 7, 2024 /PRNewswire/ -- Gateless , a visionary mortgage technology company, proudly announces its integration with Freddie Mac's AIM Check application programing interface (API).
  • This integration links Gateless' intelligent automation products with Freddie Mac's AIM Check API allowing lenders to benefit from an early income assessment from Loan Product Advisor® (LPASM).
  • Gateless customers can take advantage of this opportunity by leveraging either its flagship product Smart Underwrite™, or its latest offering VeriClear™.
  • "After spending two years, heads down, building what we believe to be business transforming solutions, this collaboration with Freddie Mac, further validates our work at Gateless," said Rick Lang, Gateless President.

RAW TRAVEL SEASON 12 (2024-25) ANNOUNCED "FIRM GO"

Retrieved on: 
Tuesday, February 6, 2024
Disability, AIM, Travel, Season, History, Television, News, Host, City, Organization

NEW YORK, Feb. 6, 2024 /PRNewswire/ -- AIM Tell-A-Vision® Group (AIM TV), producers of the nation's most-watched travel show, Raw Travel®, announced today that Raw Travel has been granted a "firm go" for Season 12 (2024-25) beginning September 2024.  

Key Points: 
  • NEW YORK, Feb. 6, 2024 /PRNewswire/ -- AIM Tell-A-Vision® Group (AIM TV), producers of the nation's most-watched travel show, Raw Travel®, announced today that Raw Travel has been granted a "firm go" for Season 12 (2024-25) beginning September 2024.
  • Season 12 will ride off the momentum generated by the current Season 11, which utilizes Raw Travel's massive 200-episode evergreen library from the last ten seasons, which has been a hit.
  • Raw Travel is a proven performer as a great alternative and adjacency for the weekends for sports-themed content," Rose continued.
  • Raw Travel's Season 11 is currently watchable on an all-time high of over 200 TV stations in 185 cities, representing over 97% of U.S. television homes.

Piedmont Lithium Provides Corporate Update

Retrieved on: 
Tuesday, February 6, 2024
General Automotive, Automotive Manufacturing, EV, Electric Vehicles, Manufacturing, Alternative Vehicles, Fuels, Automotive, Environmental Health, Alternative Energy, Energy, Environment, Mining, Minerals, Sustainability, Natural Resources, Green Technology, Lithium, ADI, Minerals Income Investment Fund, AIM, Legislation, Comment, Transport, Piedmont Lithium, NAL, Australian Securities Exchange, XV, Atmosphere, Workforce, 600 (number), District court, Accident, Weather, Acquisition, Risk, Record, ALL, ASX, PLL

Piedmont Lithium (“Piedmont” or the “Company”) (Nasdaq: PLL; ASX: PLL), a leading global supplier of lithium resources critical to the U.S. electric vehicle (“EV”) supply chain, today provided an update on key business and portfolio activities.

Key Points: 
  • Piedmont Lithium (“Piedmont” or the “Company”) (Nasdaq: PLL; ASX: PLL), a leading global supplier of lithium resources critical to the U.S. electric vehicle (“EV”) supply chain, today provided an update on key business and portfolio activities.
  • “We are very pleased with the progress at NAL and anticipate continued operating improvements through 2024," said Keith Phillips, President and Chief Executive Officer of Piedmont Lithium.
  • Our projects include our Carolina Lithium and Tennessee Lithium projects in the United States and partnerships in Quebec with Sayona Mining (ASX: SYA) and in Ghana with Atlantic Lithium (AIM: ALL; ASX: A11).
  • Piedmont disclaims any intent or obligation to update publicly such forward-looking statements, projections, and estimates, whether as a result of new information, future events or otherwise.

Metals Exploration Plc to Attend 121 Mining Investment Conference in Cape Town

Retrieved on: 
Monday, February 5, 2024
Conference, AIM, Mining, MTL

London, United Kingdom--(Newsfile Corp. - February 5, 2024) - Metals Exploration Plc (AIM: MTL) is pleased to announce the company is participating in the upcoming 121 Mining Investment Conference in Cape Town.

Key Points: 
  • London, United Kingdom--(Newsfile Corp. - February 5, 2024) - Metals Exploration Plc (AIM: MTL) is pleased to announce the company is participating in the upcoming 121 Mining Investment Conference in Cape Town.
  • 121 Mining Investment Cape Town will be hosting over 125 mining companies and more than 550 sophisticated investors for two days of pre-arranged, targeted 1-2-1 meetings.
  • Alongside the curated schedule of pre-booked meetings matching investors with appropriate projects, the conference programme will provide expert commentary and the latest market intelligence on key industry developments.
  • Any investors who would like to attend 121 Mining Investment Cape Town can register for a free pass here: https://hubs.la/Q02f4pD60

Change of Broker

Retrieved on: 
Monday, February 5, 2024
Limited, AIM, Nasdaq Iceland, Gold

TORONTO, ONTARIO – February 05, 2024 – Amaroq Minerals Ltd. (AIM, TSXV, NASDAQ Iceland: AMRQ), an independent mine development company with a substantial land package of gold and strategic mineral assets in Southern Greenland, announces that its Joint UK Corporate Brokers are Stifel Nicolaus Europe Limited and Panmure Gordon (UK) Limited.

Key Points: 
  • TORONTO, ONTARIO – February 05, 2024 – Amaroq Minerals Ltd. (AIM, TSXV, NASDAQ Iceland: AMRQ), an independent mine development company with a substantial land package of gold and strategic mineral assets in Southern Greenland, announces that its Joint UK Corporate Brokers are Stifel Nicolaus Europe Limited and Panmure Gordon (UK) Limited.

Cerillion to Demonstrate Groundbreaking GenAI-powered BSS/OSS at MWC Barcelona 2024

Retrieved on: 
Monday, February 5, 2024
AIM, Cerillion, Mobile World Congress, Workflow, Natural language processing, Hall, BSS, Human, Industrial design

LONDON, Feb. 5, 2024 /PRNewswire/ -- Cerillion (AIM: CER), a leading provider of BSS/OSS-as-a-Service solutions to the telecoms sector, is set to showcase its cutting-edge GenAI-powered product catalogue at MWC Barcelona 2024.

Key Points: 
  • LONDON, Feb. 5, 2024 /PRNewswire/ -- Cerillion (AIM: CER), a leading provider of BSS/OSS-as-a-Service solutions to the telecoms sector, is set to showcase its cutting-edge GenAI-powered product catalogue at MWC Barcelona 2024.
  • Cerillion invites visitors to MWC Barcelona to experience these exciting features firsthand at Hall 7, Stand 7B61.
  • "We are thrilled to showcase our latest advancements in GenAI integration at MWC Barcelona 2024," said Louis Hall, CEO, Cerillion.
  • Meet Cerillion at MWC Barcelona from 26th – 29th February where it will be showcasing its BSS/OSS product suite and GenAI integration.